May 20, 2015 / 11:04 AM / 3 years ago

Valeant in talks to buy Egyptian drugmaker Amoun Pharma-Bloomberg

May 20 (Reuters) - Valeant Pharmaceuticals International Inc is in talks to buy Egyptian drugmaker Amoun Pharmaceutical Co to expand its veterinary and human medicines portfolio, Bloomberg reported, citing people familiar with the matter.

A sale could value Amoun at $700 million to $800 million, Bloomberg reported. (

Valeant was not immediately available for comment.

Should Amoun fail to find a buyer, it may consider an initial public offering in London, the report said.

Amoun could not be immediately reached for comment. (Reporting by Rosmi Shaji in Bengaluru; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below